The FREIA project highly values openness and sharing of information. We organise webinars to address the issue of hormone disruption and female reproductive health from various angles, addressing a wide audience.
EDC IDENTIFICATION: HOW DOES IT WORK?
a pragmatic approach to EDC identification
27 October 2020
In 2018, the European Commission adopted criteria to assess whether a biocide or pesticide is an endocrine disruptor. A guidance document was written on how to do this in practice. First, FREIA coordinator Majorie van Duursen gives brief overview of the process of EDC identification. FREIA partner Julie Boberg (Technical University of Denmark) then explains the process of EDC identification in practice, using butylparaben as an example.
Butylparaben is often used in cosmetics to prevent microbial growth. It is on the candidate list of substances of very high concern of the European Chemicals Agency for its endocrine disrupting properties.
Dr Boberg shows that butylparaben is a great example that current criteria and EDC identification tools may also be suitable for other chemical regulations.
This webinar was organised by the FREIA project together with the Health and Environment Alliance (HEAL).
17 February 2020
This webinar was co-organised by the Health and Environment Alliance (HEAL), the International Federation of Gynecology and Obstetrics (FIGO), and the International Federation of Fertility Societies (IFFS). The webinar was moderated by Genon K. Jensen (Health and Environment Alliance)
- Professor Majorie van Duursen, from the Vrije Universiteit Amsterdam and coordinator of the FREIA project, provides a short presentation to introduce the FREIA project and consortium.
- Dr. Pauliina Damdimopoulou, senior researcher at the Karolinska Institute in Stockholm, presents FREIA project data about exposure of human oocytes and babies to EDC compounds, discuss the implications, and provide an illustration of the project development.
- Dr Jeanne Conry, president-elect of the International Federation of Gynecology and Obstetrics (FIGO), provides an overview on FIGO’s commitment to improved EDC regulation as an important prevention tool.
The recording of this webinar and the presentation slides are now available for download.